Dashboard
Manage Tickers

APYX Apyx Medical Corp

Nasdaq apyxmedical.com


$ 2.92 $ -0.19 (-6.11 %)    

Friday, 17-Oct-2025 18:27:30 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 2.92
$ 3.06
$ 1.75 x 200
$ 3.50 x 100
$ 2.84 - $ 3.13
$ 0.76 - $ 3.49
48,409
na
110.43M
$ 1.57
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-13-2025 12-31-2024 10-K
4 11-08-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-21-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-16-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-17-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-31-2020 12-31-2019 10-K
24 11-15-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 03-14-2019 12-31-2018 10-K
28 11-02-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-13-2018 12-31-2017 10-K
32 11-03-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-10-2017 12-31-2016 10-K
36 10-27-2016 09-30-2016 10-Q
37 08-02-2016 06-30-2016 10-Q
38 05-11-2016 03-31-2016 10-Q
39 03-18-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

apyx-medical-submits-fda-510k-for-device-label-expansion-of-ayon-body-contouring-system
Apyx Medical Submits FDA 510(k) For Device...
10/13/2025 12:05:50

Initiated Nationwide Commercial Launch of AYON in SeptemberThe Company is Hosting a Virtual Key Opinion Leader Event to Discuss...

apyx-medical-to-host-october-14-virtual-kol-event-featuring-dr-paul-vanek-to-discuss-commercial-launch-of-ayon-body-contouring-system
Apyx Medical To Host October 14 Virtual KO...
09/29/2025 12:14:29

apyx-medical-raises-fy2025-sales-guidance-from-47600m-49000m-to-50000m-52000m-vs-48219m-est
Apyx Medical Raises FY2025 Sales Guidance ...
08/07/2025 20:09:57

apyx-medical-q2-eps-009-beats-010-estimate-sales-11373m-miss-11699m-estimate
Apyx Medical Q2 EPS $(0.09) Beats $(0.10) ...
08/07/2025 20:02:10

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

apyx-medical-launches-renuvion-in-china
Apyx Medical Launches Renuvion In China
07/28/2025 12:03:13

Strong clinical interest and early procedures completedEntered into distribution agreement with GlamMoon, a division of BeauCar...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
06/23/2025 21:06:48

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
05/14/2025 12:09:44

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 21:06:18

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 17:06:46

apyx-medical-affirms-fy2025-sales-guidance-of-4760m-4900m-vs-4803m-est
Apyx Medical Affirms FY2025 Sales Guidance...
05/08/2025 11:07:00

Apyx Medical (NASDAQ:APYX) affirms FY2025 sales outlook from $47.60 million-$49.00 million to $47.60 million-$49.00 million vs ...

apyx-medical-q1-eps-010-beats-012-estimate-sales-943m-beat-939m-estimate
Apyx Medical Q1 EPS $(0.10) Beats $(0.12) ...
05/08/2025 11:01:25

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) ...

Core News & Articles
Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

apyx-medical-revises-2025-total-revenue-outlook-from-476m---495m-to-476m---490m-est-48462m
Apyx Medical Revises 2025 Total Revenue Ou...
03/13/2025 11:08:02

The Company continues to expect operating expenses of less than $40.0 million for the year ended December 31, 2025.

apyx-medical-q4-2024-gaap-eps-012-beats-015-estimate-sales-1422m-beat-1339m-estimate
Apyx Medical Q4 2024 GAAP EPS $(0.12) Beat...
03/13/2025 11:02:56

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) ...

earnings-scheduled-for-march-13-2025
Earnings Scheduled For March 13, 2025
03/13/2025 08:32:19

apyx-medical-announces-q4-2024-revenue-between-141m-143m-a-3-4-decrease-yoy-advanced-energy-revenue-flat-at-120m-122m-oem-revenue-down-17-to-21m-fy24-revenue-between-480m-482m-an-8-decrease-yoy-advanced-energy-down-11-to-385m-387m-oem-up-6-to-95m
Apyx Medical Announces Q4 2024 Revenue Bet...
01/13/2025 13:39:11

Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofreque...

apyx-medical-corp-submits-510k-premarket-notification-to-the-us-fda-fortthe-ayon-body-contouring-system
Apyx Medical Corp Submits 510(k) Premarket...
01/06/2025 13:09:22

Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical"; the "Company"), the manufacturer of a proprietary heli...

apyx-medical-shares-are-trading-lower-after-the-company-cut-its-fy24-and-fy25-revenue-guidance
Apyx Medical shares are trading lower afte...
11/08/2024 14:31:30

apyx-medical-expects-2025-revenues-of--476m-495m-compared-to-consensus-of-54045m
Apyx Medical Expects 2025 Revenues Of $47...
11/08/2024 12:13:57

The Company is introducing revenue guidance for the year ending December 31, 2025:Total revenue in the range of $47.6 million t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION